Who we are

We are an international team including SAH survivors, researchers and clinicians currently based in two locations in Ottawa (Canada) and Sydney (Australia).

Steering Group

SAH Core Domain Set Working Group:

Lauralyn McIntyre, MD^4,6,10,11; Anthony Delaney, PhD^1,2,3; Michaël Chassé, MD¹²; Victoria Saigle, MSc ⁴; Madeline McCoy, MSc⁴; Shawn Marshall, MD ^4,11; Dean A Fergusson, PhD^5,11; Ian D. Graham, PhD^5,6; Jamie Brehaut, MD^4,6; Alexis F. Turgeon, MD^13,14; François Lauzier, MD^14,15; Peter Tugwell, PhD^5,6,11,16; Xiaohui Zha, PhD^†11; Phil Talbot, BSc^†2; John Muscedere, MD¹⁷; John C Marshall, MD¹⁸; Kednapa Thavorn, PhD^5,6; Donald E.G. Griesdale, MD^19,20; Rachel Clouthier, RN¹⁰; Emily Fitzgerald, RN²; Jessica Haines, RN¹⁰; Rebecca Porteous, BNSc¹⁰; Angie Tuttle⁴; SAH Domain Definitions Working Group, Canadian Critical Care Trials Group⁺

¹²Department of Medicine, Division of Critical Care, Centre Hospitalier de l’Université de Montréal, Montréal, Québec, Canada

¹³Department of Anesthesiology and Critical Care, Division of Critical Care Medicine, Université Laval, Québec City, Québec, Canada

¹⁴Population Health and Optimal Health Practice Research Unit (Trauma — Emergency — Critical Care Medicine), CHU de Québec-Université Laval Research Centre, Québec City, Québec, Canada

¹⁵Department of Medicine, Department of Anesthesiology and Critical Care, Université Laval, Québec, Canada

¹⁶Bruyère Health Research Institute, Ottawa, ON, Canada  

¹⁷Department of Critical Care Medicine, Queen’s University, Kingston, ON, Canada

¹⁸Departments of Surgery and Critical Care Medicine, Unity Health Toronto, Toronto, ON, Canada

¹⁹Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, BC, Canada

²⁰Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada

SAH Core Domain Definitions Working Group:

Gordon Fernie, PhD⁴; Behnam Rezai Jahromi, MD PhD²¹; Suszanne May^†; Vincent Ng, MD²²; Madeline F. Christenson^†; Christine J. Buckley²³; Ian Galea, PhD²⁴; Marjorie Nicholson^†; Sepideh Amin-Hanjani, MD²⁵; Miriam M. Treggiari, MD, PhD²⁶; Tracy Iona^†; Amr Abdulazim, MD²⁷; Michael Hugelshofer, MD²⁸; Jose I. Suarez, MD²⁹; Maria Luisa Marti^†;  J. Sarah Houlton, PhD ^23†; Sherry H-Y. Chou, MD MSc ³⁰; P. Roc Chen, MD³¹; Isabel C. Hostettler, MD^7,8; Elisa Cuadrado-Godia, MD PhD³²; Lachlan H. Donaldson, MD²; Megan Saliterman^†; Alicia Smart^†; Leslie A. Miller, PhD^33†; Sarah E. Nelson, MD³⁴; Susan M. Farnsworth^†; Stephan A. Mayer, MD³⁵; David M. Hasan, MD³⁶; Redi Rahmani, MD⁹; Jens P. Dreier, MD³⁷; Hemant Bhagat, MD³⁸; Ronil V. Chandra, MD³⁹; Lora Owens^†; Katharina M. Busl, MD⁴⁰ and Mervyn D.I. Vergouwen, MD ⁴¹

²¹Department of Neurosurgery, Helsinki University Hospital, University of Helsinki, Helsinki, Finland

²²Neurosurgery Department, National Neuroscience Institute, Singapore

²³Brain Aneurysm Foundation, Hanover, MA, USA

²⁴Clinical Neurosciences, Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, UK

²⁵Department of Neurosurgery, University Hospitals Cleveland Medical Center/Case Western Reserve University School of Medicine, Cleveland, OH, USA

²⁶Duke University, NC, USA

²⁷Department of Neurosurgery, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany

²⁸Department of Neurosurgery, University Hospital Zurich, Zurich, Switzerland

²⁹Departments of Anesthesiology and Critical Care Medicine, Neurology, and Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

³⁰Northwestern University Feinberg School of Medicine, Chicago, IL, USA

³¹McGovern Medical School, University of Texas, Houston, TX, USA

³²Department of Neurology, Hospital del Mar, Universitat Pompeu Fabra, Barcelona, Spain

³³Organizational Leadership, University of Oklahoma, OK, USA

³⁴Tufts Medical Center, Boston, MA, USA

³⁵Neurocritical Care and Emergency Neurology Services, Westchester Medical Center Health System, New York Medical College, Valhalla, NY, USA

³⁶Neurosurgery, Duke University School of Medicine, Durham, NC, USA

³⁷Center for Stroke Research Berlin – Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany

³⁸Division of Neuroanaesthesiology and Neurocritical Care, Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research, Chandigarh, India

³⁹Dept of Radiology & Radiological Science, Monash Health and Monash University, Melbourne, VIC, Australia

⁴⁰Department of Neurology & Neurosurgery, University of Florida, Gainesville, FL, USA

⁴¹Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands

⁺A list of authors and their affiliations appears at the end of the paper

^†Lived experience partner

DISCLOSURES

Prof. Busl is supported by the National Institute Of Neurological Disorders And Stroke of the National Institutes of Health under Award Number U01NS124613 for BLOCK-SAH, a phase II multicenter RCT of Pterygopalatine Fossa Block as an Opioid-Sparing Treatment for Acute Headache in Aneurysmal Subarachnoid Hemorrhage. K.B. receives compensation as Associate Editor for Critical Care Medicine.

Dr. Chen declares research grants from Stryker and Balt Neurovascular.

Dr. Chou reports compensation from Grace Therapeutics for services on the scientific advisory board for STRIVE-ON trial; service as Board of Directors member for the United Council for Neurologic Subspecialties; research grants from the Neurocritical Care Society.  Dr. Chou serves on the Editorial Board for Stroke and serves as associate editor for Translational Stroke Research.

Dr. Hasan is a member of the Data and Safety Monitoring Board for a SAH clinical trial sponsored by Acasti Pharma Inc. and a member of the NINDS-funded Stroke CDE (Common Data Elements) oversight committee and co-Chair of the NINDS-funded SAH CDE project.

Dr. Mayer has received consulting fees from Idorsia Pharmaceuticals.

Dr. Nelson is co-editor of a neurocritical care textbook for which royalties are received.

Dr. Rezai Jahromi is the owner of Neurovascular Innovations, patents granted and pending on aneurysms imaging and treatment. Prof. Tugwell is the [unpaid] Chair of the Management Group of a registered non-profit independent medical research organization, OMERACT, whose goal is to improve and advance the health outcomes for patients suffering from musculoskeletal conditions. OMERACT receives arms-length funding from 11 companies (Abbvie, Astra Zenaca, Aurinia, BMS, Centrexion, GSK, Horizon Pharma Inc , Janssen, Novartis, Pfizer & Sparrow).